60 Recruiting Breast Cancer Phase 2 Clinical Trials
Active phase 2 studies for breast cancer enrolling across the USA. Verify eligibility and contact site coordinators.
All Breast Cancer studiesPhase 2 Studies for Breast Cancer
TACTIVE-U: A Study to Learn About the Study Medicine (Vepdegestrant) When Given With Other Medicines in People With Advanced or Metastatic Breast Cancer (Sub-Study B)
📍 Stanford Women's Cancer Center — Palo Alto, California
View Study & Checklist ➔ATOP TRIAL: T-DM1 in HER2 Positive Breast Cancer
📍 City of Hope Comprehensive Cancer Center — Duarte, California
View Study & Checklist ➔Phase II Study of Pembrolizumab and Nab-paclitaxel in HER-2 Negative Metastatic Breast Cancer
📍 NYU Perlmutter Cancer Center — New York, New York
View Study & Checklist ➔CFI-402257 in Combination With Paclitaxel in Patients With Advanced/Metastatic HER2-Negative Breast Cancer
📍 BCCA - Vancouver Cancer Centre — Vancouver, British Columbia
View Study & Checklist ➔NIMBUS: Nivolumab Plus Ipilimumab in Metastatic Hypermutated HER2-negative Breast Cancer
📍 Dana-Farber Cancer Institute — Boston, Massachusetts
View Study & Checklist ➔Study of Zelenectide Pevedotin in Participants With Advanced Breast Cancer
📍 Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (SKCCC) — Baltimore, Maryland
View Study & Checklist ➔Tucatinib+Trastuzumab+Eribulin in HER2+ MBC
📍 University of Colorado — Aurora, Colorado
View Study & Checklist ➔The Effect of Acupuncture on Nerve Pain Caused by Taxane (Chemotherapy) Treatment
📍 Memorial Sloan Kettering Basking Ridge — Basking Ridge, New Jersey
View Study & Checklist ➔Neoadjuvant Endocrine Therapy, Palbociclib, Avelumab in Estrogen Receptor Positive Breast Cancer
📍 University of Alabama at Birmingham — Birmingham, Alabama
View Study & Checklist ➔A Study of Olaparib and Pembrolizumab in People With Triple Negative Breast Cancer (TNBC) or Hormone Receptor-positive HER2-negative Breast Cancer
📍 Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) — Basking Ridge, New Jersey
View Study & Checklist ➔Breast Cancer Study of Preoperative Pembrolizumab + Radiation
📍 Cedars-Sinai Medical Center — Los Angeles, California
View Study & Checklist ➔Preoperative Single-Fraction Radiotherapy in Early Stage Breast Cancer
📍 Duke Cancer Center — Durham, North Carolina
View Study & Checklist ➔Pertuzumab and Trastuzumab as Neoadjuvant Treatment in Patients With HER2-Positive Breast Cancer
📍 University of Alabama Comprehensive Cancer Center — Birmingham, Alabama
View Study & Checklist ➔Study of LEE011, BYL719 and Letrozole in Advanced ER+ Breast Cancer
📍 Univ of California at San Diego Moores Cancer Ctr — San Diego, California
View Study & Checklist ➔Docosahexaenoic Acid (DHA) for Women With Breast Cancer in the Neoadjuvant Setting
📍 Cross Cancer Institute — Edmonton, Alberta
View Study & Checklist ➔TACTIVE-U: A Study to Learn About the Study Medicine (Vepdegestrant) When Given With Other Medicines in People With Advanced or Metastatic Breast Cancer. (Sub-Study C)
📍 Highlands Oncology Group — Fayetteville, Arkansas
View Study & Checklist ➔Bioequivalence ANDA SNP Clinical Study - Raloxifene and Single Nucleotide Polymorphisms
📍 Medicine Invention Design, Inc. - IORG0007849 - NPI 1023387701 — Rockville, Maryland
View Study & Checklist ➔DNA-guided Second Line Adjuvant Therapy for High Residual Risk, Estrogen Receptor Positive, HER-2 Negative Breast Cancer (DARE)
📍 University of Arizona Cancer Center — Tucson, Arizona
View Study & Checklist ➔Abraxane® With or Without Mifepristone for Advanced, Glucocorticoid Receptor-Positive, Triple-Negative Breast Cancer
📍 University of Alabama - Birmingham — Birmingham, Alabama
View Study & Checklist ➔The Effect of Acupuncture on Cancer-Related Cognitive Difficulties
📍 Memorial Sloan Kettering Basking Ridge (Limited Protocol activities) — Basking Ridge, New Jersey
View Study & Checklist ➔Open-Label Umbrella Study To Evaluate Safety And Efficacy Of Elacestrant In Various Combination In Participants With Metastatic Breast Cancer
📍 Dothan Hematology and Oncology — Dothan, Alabama
View Study & Checklist ➔Study of Pembrolizumab Plus Fulvestrant in Hormone Receptor Positive, HER-2 Negative Advanced/Metastatic Breast Cancer Patients
📍 Michigan State University, Breslin Cancer Center — Lansing, Michigan
View Study & Checklist ➔Evaluating the Safety and Efficacy of a Novel Accelerated Partial Breast Irradiation Regimen
📍 Sanford Health — Worthington, Minnesota
View Study & Checklist ➔The AVIATOR Study: Trastuzumab and Vinorelbine With Avelumab OR Avelumab & Utomilumab in Advanced HER2+ Breast Cancer
📍 University of Alabama at Birmingham — Birmingham, Alabama
View Study & Checklist ➔CFI-400945 in Patients With Advanced/Metastatic Breast Cancer
📍 Juravinski Cancer Centre at Hamilton Health Sciences — Hamilton, Ontario
View Study & Checklist ➔A Study of Flibanserin in Breast Cancer Survivors on Tamoxifen or Aromatase Inhibitors
📍 Norwalk Hospital — Norwalk, Connecticut
View Study & Checklist ➔Study of Neoadjuvant Olaparib Monotherapy and Olaparib and Durvalumab Combination in HER2 Negative BRCAm Breast Cancer
📍 Research Site — Greeley, Colorado
View Study & Checklist ➔Palbociclib and Endocrine Therapy for LObular Breast Cancer Preoperative Study (PELOPS)
📍 Stamford Hospital — Stamford, Connecticut
View Study & Checklist ➔A Study to Learn About Vepdegestrant When Given With PF-07220060 to People With Advanced or Metastatic Breast Cancer.
📍 Highlands Oncology — Fayetteville, Arkansas
View Study & Checklist ➔Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions)
📍 Dignity Health St Joseph's Hospital and Medical Center — Phoenix, Arizona
View Study & Checklist ➔Clinical Trial Assessing the Safety of Neoadjuvant Palbociclib in Combination With Endocrine Therapy
📍 Unversity of Nebraska Medical Center — Omaha, Nebraska
View Study & Checklist ➔Preventing High Blood Sugar in People Being Treated for Metastatic Breast Cancer
📍 Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) — Basking Ridge, New Jersey
View Study & Checklist ➔Extension Study of Lapatinib Plus Herceptin With or Without Endocrine Therapy
📍 University of Alabama - Birmingham — Birmingham, Alabama
View Study & Checklist ➔Neoadjuvant Endocrine Therapy in ER-positive, HER2-negative Early Stage Breast Cancer
📍 University of Kentucky Markey Cancer Center — Lexington, Kentucky
View Study & Checklist ➔A Study of the Body's Response to Exercise and a Plant-Based Diet in Overweight Postmenopausal Women With Breast Cancer
📍 Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) — Basking Ridge, New Jersey
View Study & Checklist ➔Carboplatin +/- Nivolumab in Metastatic Triple Negative Breast Cancer
📍 The Stamford Hospital — Stamford, Connecticut
View Study & Checklist ➔Preoperative Fulvestrant With or Without Enzalutamide in ER+/Her2- Breast Cancer
📍 University of Colorado — Aurora, Colorado
View Study & Checklist ➔STOP-HER2: Stopping Trastuzumab in HER2+ MBC
📍 Mayo Clinic Hospital Arizona — Phoenix, Arizona
View Study & Checklist ➔Partial Breast Irradiation (PBI) Using 40 Gy for Select Patients With Early Invasive or Noninvasive Breast Cancer
📍 Memorial Sloan Kettering at Basking Ridge (Follow-up Only) — Basking Ridge, New Jersey
View Study & Checklist ➔Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients of Different Ages With Metastatic Breast Cancer
📍 City of Hope Medical Center — Duarte, California
View Study & Checklist ➔TRADE: Dose Escalation Tolerability of Abemaciclib in HR+ HER2- Early Stage Breast Cancer
📍 Stamford Hospital — Stamford, Connecticut
View Study & Checklist ➔Study to Evaluate Sacituzumab Govitecan in Combination With Talazoparib in Patients With Metastatic Breast Cancer.
📍 Massachusetts General Hospital Cancer Center — Boston, Massachusetts
View Study & Checklist ➔Aggressive Local Therapy for Limited Bone-Only Metastasis to Improve Progression-Free Survival in Breast Cancer Patients
📍 University of Texas MD Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔Pembrolizumab, IRX-2, and Chemotherapy in Triple Negative Breast Cancer
📍 Providence Portland Medical Center — Portland, Oregon
View Study & Checklist ➔BreastVAX: Radiation Boost to Enhance Immune Checkpoint Blockade Therapy
📍 Perelman Center for Advanced Medicine — Philadelphia, Pennsylvania
View Study & Checklist ➔Radiation Therapy in Treating Women With Early Stage Breast Cancer
📍 RWJBarnabas Health - Robert Wood Johnson University Hospital — Hamilton, New Jersey
View Study & Checklist ➔Carboplatin and Nab-Paclitaxel With or Without Vorinostat in Treating Women With Newly Diagnosed Operable Breast Cancer
📍 University of Alabama Comprehensive Cancer Center — Birmingham, Alabama
View Study & Checklist ➔Study of Stereotactic Radiosurgery With Olaparib Followed by Durvalumab and Physician's Choice Systemic Therapy in Subjects With Breast Cancer Brain Metastases
📍 University of Alabama at Birmingham — Birmingham, Alabama
View Study & Checklist ➔A Study of Tobemstomig + Nab-Paclitaxel Compared With Pembrolizumab + Nab-Paclitaxel in Participants With Previously Untreated, PD-L1-Positive, Locally-Advanced Unresectable or Metastatic Triple-Negative Breast Cancer
📍 Cancer Blood and Specialty Clinic — Los Alamitos, California
View Study & Checklist ➔A Study to Learn About the Study Medicine (Called PF-07220060 in Combination With PF-07104091) In Participants With Breast Cancer and Solid Tumors
📍 Administrative Address: UCLA Hematology/Oncology — Los Angeles, California
View Study & Checklist ➔Durvalumab With Trastuzumab and Pertuzumab in HER2-Enriched Breast Cancer
📍 Houston Methodist Cancer Center — Houston, Texas
View Study & Checklist ➔Letrozole Plus Ribociclib or Placebo as Neo-adjuvant Therapy in ER-positive, HER2-negative Early Breast Cancer
📍 University of Arkansas for Medical Sciences — Little Rock, Arkansas
View Study & Checklist ➔A Novel Therapy for Breast Cancer Survivors With Genitourinary Syndrome of Menopause
📍 University of Miami — Miami, Florida
View Study & Checklist ➔Feasibility Study of Adjuvant Enzalutamide for the Treatment of Early Stage AR (+) Triple Negative Breast Cancer
📍 Hartford Healthcare Cancer Institute @ Hartford Hospital — Hartford, Connecticut
View Study & Checklist ➔Levels of Circulating Tumor DNA as a Predictive Marker for Early Switch in Treatment for Patients With Metastatic (Stage IV) Breast Cancer
📍 University of Miami — Miami, Florida
View Study & Checklist ➔TALAVE: Induction Talazoparib Followed by Combination of Talazoparib and Avelumab in Advanced Breast Cancer
📍 MedStar Georgetown University Hospital — Washington D.C., District of Columbia
View Study & Checklist ➔A Study Evaluating the Efficacy and Safety of Inavolisib + Palbociclib + Fulvestrant vs Placebo + Palbociclib + Fulvestrant in Participants With PIK3CA-Mutant, Hormone Receptor-Positive, HER2-Negative, Locally Advanced or Metastatic Breast Cancer
📍 Beverly Hills Cancer Center — Beverly Hills, California
View Study & Checklist ➔TACTIVE-U: A Study to Learn About the Study Medicine (Vepdegestrant) When Given With Other Medicines in People With Advanced or Metastatic Breast Cancer (Sub-Study A)
📍 Stanford Women's Cancer Center — Palo Alto, California
View Study & Checklist ➔Combination Chemotherapy With or Without Trastuzumab in Treating Patients With Stage II or Stage III Breast Cancer
📍 City of Hope Medical Center — Duarte, California
View Study & Checklist ➔Accelerated Radiation Therapy (ART) to the Breast and Nodal Stations
📍 New York Presbyterian Hospital - Queens — New York, New York
View Study & Checklist ➔